resound (health) limited
resound (health) limited Company Information
Company Number
05168336
Next Accounts
Dec 2025
Shareholders
lift investments ltd
community health partnerships ltd
Group Structure
View All
Industry
Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
Registered Address
9th floor cobalt square, 83-85 hagley road, birmingham, B16 8QG
resound (health) limited Estimated Valuation
Pomanda estimates the enterprise value of RESOUND (HEALTH) LIMITED at £274.4k based on a Turnover of £424k and 0.65x industry multiple (adjusted for size and gross margin).
resound (health) limited Estimated Valuation
Pomanda estimates the enterprise value of RESOUND (HEALTH) LIMITED at £0 based on an EBITDA of £-10k and a 2.71x industry multiple (adjusted for size and gross margin).
resound (health) limited Estimated Valuation
Pomanda estimates the enterprise value of RESOUND (HEALTH) LIMITED at £189.2k based on Net Assets of £145k and 1.31x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Resound (health) Limited Overview
Resound (health) Limited is a live company located in birmingham, B16 8QG with a Companies House number of 05168336. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in July 2004, it's largest shareholder is lift investments ltd with a 60% stake. Resound (health) Limited is a mature, micro sized company, Pomanda has estimated its turnover at £424k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Resound (health) Limited Health Check
Pomanda's financial health check has awarded Resound (Health) Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs
1 Strong
1 Regular
7 Weak
Size
annual sales of £424k, make it smaller than the average company (£19.1m)
£424k - Resound (health) Limited
£19.1m - Industry AVG
Growth
3 year (CAGR) sales growth of 12%, show it is growing at a similar rate (11.7%)
12% - Resound (health) Limited
11.7% - Industry AVG
Production
with a gross margin of 7.6%, this company has a higher cost of product (34.9%)
7.6% - Resound (health) Limited
34.9% - Industry AVG
Profitability
an operating margin of -2.4% make it less profitable than the average company (4.6%)
-2.4% - Resound (health) Limited
4.6% - Industry AVG
Employees
with 3 employees, this is below the industry average (105)
- Resound (health) Limited
105 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Resound (health) Limited
- - Industry AVG
Efficiency
resulting in sales per employee of £141.3k, this is less efficient (£190.5k)
- Resound (health) Limited
£190.5k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Resound (health) Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 5 days, this is quicker than average (43 days)
5 days - Resound (health) Limited
43 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Resound (health) Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 28 weeks, this is more cash available to meet short term requirements (14 weeks)
28 weeks - Resound (health) Limited
14 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 94.6%, this is a higher level of debt than the average (68.7%)
94.6% - Resound (health) Limited
68.7% - Industry AVG
RESOUND (HEALTH) LIMITED financials
Resound (Health) Limited's latest turnover from March 2024 is £424 thousand and the company has net assets of £145 thousand. According to their latest financial statements, we estimate that Resound (Health) Limited has 3 employees and maintains cash reserves of £183 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 424,000 | 495,000 | 374,000 | 305,000 | 162,000 | 300,000 | 327,000 | 535,000 | 448,000 | 218,000 | 728,000 | 417,000 | 289,058 | 2,629,831 | 209,988 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 392,000 | 453,000 | 334,000 | 137,000 | 135,000 | 150,000 | 372,000 | 272,000 | 67,000 | 548,000 | 273,000 | 84,116 | 2,475,698 | ||
| Gross Profit | 32,000 | 42,000 | 40,000 | 168,000 | 162,000 | 165,000 | 177,000 | 163,000 | 176,000 | 151,000 | 180,000 | 144,000 | 204,942 | 154,133 | 209,988 |
| Admin Expenses | 42,000 | 37,000 | 32,000 | 203,000 | 195,000 | 287,000 | 212,000 | 180,000 | 194,000 | 201,000 | 197,000 | 158,000 | 152,968 | 152,392 | 185,792 |
| Operating Profit | -10,000 | 5,000 | 8,000 | -35,000 | -33,000 | -122,000 | -35,000 | -17,000 | -18,000 | -50,000 | -17,000 | -14,000 | 51,974 | 1,741 | 24,196 |
| Interest Payable | 283,000 | 291,000 | 302,000 | 311,000 | 329,000 | 360,000 | 364,000 | 364,000 | 370,000 | 373,000 | 379,000 | 385,000 | 2 | 3 | 2 |
| Interest Receivable | 284,000 | 291,000 | 302,000 | 311,000 | 329,000 | 360,000 | 364,000 | 364,000 | 370,000 | 373,000 | 379,000 | 386,000 | 331 | 302 | 109 |
| Pre-Tax Profit | 409,000 | 163,000 | 217,000 | 16,000 | 469,000 | -122,000 | -35,000 | -17,000 | -18,000 | -50,000 | -17,000 | -13,000 | 52,303 | 2,040 | 24,303 |
| Tax | -45,000 | 21,000 | 6,000 | 2,000 | 2,000 | 8,000 | 3,000 | 3,000 | 60 | ||||||
| Profit After Tax | 409,000 | 163,000 | 217,000 | 16,000 | 424,000 | -101,000 | -29,000 | -15,000 | -16,000 | -42,000 | -14,000 | -10,000 | 52,363 | 2,040 | 24,303 |
| Dividends Paid | 518,000 | 158,000 | 209,000 | 51,000 | |||||||||||
| Retained Profit | -109,000 | 5,000 | 8,000 | -35,000 | 424,000 | -101,000 | -29,000 | -15,000 | -16,000 | -42,000 | -14,000 | -10,000 | 52,363 | 2,040 | 24,303 |
| Employee Costs | 96,000 | 96,000 | 94,710 | 93,364 | 95,073 | ||||||||||
| Number Of Employees | 2 | 2 | 2 | 2 | |||||||||||
| EBITDA* | -10,000 | 5,000 | 8,000 | -35,000 | -33,000 | -122,000 | -35,000 | -12,000 | -17,000 | -47,000 | -14,000 | -13,000 | 52,087 | 2,066 | 25,809 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 5,000 | 6,000 | 9,000 | 1,000 | 2,119 | 972 | 1,297 | ||||||||
| Intangible Assets | |||||||||||||||
| Investments & Other | 2,187,000 | 2,239,000 | 2,348,000 | 2,440,000 | 2,551,000 | 2,618,000 | 2,670,000 | 3 | 3 | 3 | |||||
| Debtors (Due After 1 year) | 45,000 | 2,908,000 | 2,965,000 | 3,038,000 | 3,112,000 | 3,160,000 | |||||||||
| Total Fixed Assets | 2,187,000 | 2,239,000 | 2,348,000 | 2,440,000 | 2,551,000 | 2,663,000 | 2,670,000 | 2,908,000 | 2,970,000 | 3,044,000 | 3,121,000 | 3,161,000 | 2,122 | 975 | 1,300 |
| Stock & work in progress | |||||||||||||||
| Trade Debtors | 22,000 | 54,000 | 138,000 | 96,000 | 62,000 | 9,000 | 81,000 | 250,000 | 102,346 | 39,685 | 725,335 | ||||
| Group Debtors | 289,000 | 374,000 | 360,000 | 293,000 | 66,000 | 525,000 | 320,000 | 262,000 | 494,000 | 430,000 | 325,000 | 301,000 | 197,350 | 277,197 | 180,369 |
| Misc Debtors | 5,000 | 15,000 | 4,000 | 14,000 | 10,000 | 8,000 | 119,000 | 77,000 | 131,000 | 35,000 | 189,000 | 138,000 | 2,938 | 771 | 689,920 |
| Cash | 183,000 | 368,000 | 240,000 | 281,000 | 287,000 | 332,000 | 276,000 | 364,000 | 175,000 | 355,000 | 350,000 | 358,000 | 364,925 | 337,852 | 981,773 |
| misc current assets | |||||||||||||||
| total current assets | 477,000 | 757,000 | 626,000 | 588,000 | 363,000 | 919,000 | 853,000 | 799,000 | 862,000 | 829,000 | 945,000 | 1,047,000 | 667,559 | 655,505 | 2,577,397 |
| total assets | 2,664,000 | 2,996,000 | 2,974,000 | 3,028,000 | 2,914,000 | 3,582,000 | 3,523,000 | 3,707,000 | 3,832,000 | 3,873,000 | 4,066,000 | 4,208,000 | 669,681 | 656,480 | 2,578,697 |
| Bank overdraft | |||||||||||||||
| Bank loan | 689,155 | ||||||||||||||
| Trade Creditors | 6,000 | 107,000 | 27,000 | 57,000 | 1,000 | 88,000 | 46,000 | 67,000 | 16,000 | 5,000 | 63,000 | 1,508 | 2,901 | 3,471 | |
| Group/Directors Accounts | 118,000 | 109,000 | 92,000 | 89,000 | 64,000 | 486,000 | 309,000 | 234,000 | 275,000 | 272,000 | 266,000 | 72,000 | 15,540 | ||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 208,000 | 287,000 | 258,000 | 201,000 | 22,000 | 36,000 | 89,000 | 35,000 | 26,000 | 32,000 | 126,000 | 342,000 | 87,468 | 109,697 | 1,359,769 |
| total current liabilities | 332,000 | 503,000 | 377,000 | 347,000 | 87,000 | 610,000 | 398,000 | 315,000 | 368,000 | 320,000 | 397,000 | 477,000 | 88,976 | 128,138 | 2,052,395 |
| loans | 2,187,000 | 2,239,000 | 2,348,000 | 2,440,000 | 2,551,000 | 2,618,000 | 2,670,000 | 2,908,000 | 2,965,000 | 3,038,000 | 3,112,000 | 3,160,000 | |||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | 2,187,000 | 2,239,000 | 2,348,000 | 2,440,000 | 2,551,000 | 2,618,000 | 2,670,000 | 2,908,000 | 2,965,000 | 3,038,000 | 3,112,000 | 3,160,000 | |||
| total liabilities | 2,519,000 | 2,742,000 | 2,725,000 | 2,787,000 | 2,638,000 | 3,228,000 | 3,068,000 | 3,223,000 | 3,333,000 | 3,358,000 | 3,509,000 | 3,637,000 | 88,976 | 128,138 | 2,052,395 |
| net assets | 145,000 | 254,000 | 249,000 | 241,000 | 276,000 | 354,000 | 455,000 | 484,000 | 499,000 | 515,000 | 557,000 | 571,000 | 580,705 | 528,342 | 526,302 |
| total shareholders funds | 145,000 | 254,000 | 249,000 | 241,000 | 276,000 | 354,000 | 455,000 | 484,000 | 499,000 | 515,000 | 557,000 | 571,000 | 580,705 | 528,342 | 526,302 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | -10,000 | 5,000 | 8,000 | -35,000 | -33,000 | -122,000 | -35,000 | -17,000 | -18,000 | -50,000 | -17,000 | -14,000 | 51,974 | 1,741 | 24,196 |
| Depreciation | 5,000 | 1,000 | 3,000 | 3,000 | 1,000 | 113 | 325 | 1,613 | |||||||
| Amortisation | |||||||||||||||
| Tax | -45,000 | 21,000 | 6,000 | 2,000 | 2,000 | 8,000 | 3,000 | 3,000 | 60 | ||||||
| Stock | |||||||||||||||
| Debtors | -95,000 | 3,000 | 79,000 | 231,000 | -556,000 | 55,000 | -2,766,000 | -309,000 | 140,000 | -195,000 | -142,000 | 3,546,366 | -15,019 | -1,277,971 | 1,595,624 |
| Creditors | -101,000 | 80,000 | -30,000 | 56,000 | -87,000 | 88,000 | -46,000 | -21,000 | 51,000 | 11,000 | -58,000 | 61,492 | -1,393 | -570 | 3,471 |
| Accruals and Deferred Income | -79,000 | 29,000 | 57,000 | 179,000 | -14,000 | -53,000 | 54,000 | 9,000 | -6,000 | -94,000 | -216,000 | 254,532 | -22,229 | -1,250,072 | 1,359,769 |
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | -95,000 | 111,000 | -44,000 | -31,000 | 377,000 | -121,000 | 2,745,000 | 287,000 | -110,000 | 73,000 | -143,000 | -3,240,342 | 43,544 | 29,395 | -206,575 |
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | -52,000 | -109,000 | -92,000 | -111,000 | -67,000 | -52,000 | 2,670,000 | -3 | 3 | ||||||
| cash flow from investments | -2,670,000 | ||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | -689,155 | 689,155 | |||||||||||||
| Group/Directors Accounts | 9,000 | 17,000 | 3,000 | 25,000 | -422,000 | 177,000 | 75,000 | -41,000 | 3,000 | 6,000 | 194,000 | 72,000 | -15,540 | 15,540 | |
| Other Short Term Loans | |||||||||||||||
| Long term loans | -52,000 | -109,000 | -92,000 | -111,000 | -67,000 | -52,000 | -238,000 | -57,000 | -73,000 | -74,000 | -48,000 | 3,160,000 | |||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | 1,000 | 1,000 | 329 | 299 | 107 | ||||||||||
| cash flow from financing | -42,000 | -92,000 | -89,000 | -86,000 | -991,000 | 125,000 | -163,000 | -98,000 | -70,000 | -68,000 | 146,000 | 3,233,295 | -15,211 | -673,316 | 1,191,261 |
| cash and cash equivalents | |||||||||||||||
| cash | -185,000 | 128,000 | -41,000 | -6,000 | -45,000 | 56,000 | -88,000 | 189,000 | -180,000 | 5,000 | -8,000 | -6,925 | 27,073 | -643,921 | 981,773 |
| overdraft | |||||||||||||||
| change in cash | -185,000 | 128,000 | -41,000 | -6,000 | -45,000 | 56,000 | -88,000 | 189,000 | -180,000 | 5,000 | -8,000 | -6,925 | 27,073 | -643,921 | 981,773 |
resound (health) limited Credit Report and Business Information
Resound (health) Limited Competitor Analysis
Perform a competitor analysis for resound (health) limited by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other micro companies, companies in B16 area or any other competitors across 12 key performance metrics.
resound (health) limited Ownership
RESOUND (HEALTH) LIMITED group structure
Resound (Health) Limited has 3 subsidiary companies.
Ultimate parent company
2 parents
RESOUND (HEALTH) LIMITED
05168336
3 subsidiaries
resound (health) limited directors
Resound (Health) Limited currently has 5 directors. The longest serving directors include Mr Rodney Chilcott (Feb 2015) and Mrs Charlotte Douglass (Aug 2017).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Rodney Chilcott | United Kingdom | 59 years | Feb 2015 | - | Director |
| Mrs Charlotte Douglass | England | 46 years | Aug 2017 | - | Director |
| Ms Elaine Siew | United Kingdom | 57 years | Sep 2024 | - | Director |
| Mr Akinola Amusu | England | 48 years | Dec 2024 | - | Director |
| Ms Francesca Kavanagh | United Kingdom | 39 years | Feb 2025 | - | Director |
P&L
March 2024turnover
424k
-14%
operating profit
-10k
-300%
gross margin
7.6%
-11.05%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
145k
-0.43%
total assets
2.7m
-0.11%
cash
183k
-0.5%
net assets
Total assets minus all liabilities
Similar Companies
resound (health) limited company details
company number
05168336
Type
Private limited with Share Capital
industry
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
incorporation date
July 2004
age
21
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
GOODMAN JONES LLP
address
9th floor cobalt square, 83-85 hagley road, birmingham, B16 8QG
Bank
-
Legal Advisor
-
resound (health) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 5 charges/mortgages relating to resound (health) limited. Currently there are 5 open charges and 0 have been satisfied in the past.
resound (health) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for RESOUND (HEALTH) LIMITED. This can take several minutes, an email will notify you when this has completed.
resound (health) limited Companies House Filings - See Documents
| date | description | view/download |
|---|
